Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03914742 |
|---|---|
| Brief Title: | BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations |
| First Submitted : | April 11, 2019 |
| First Submitted that Met QC Criteria : | April 11, 2019 |
| First Posted : | April 16, 2019 |
| Last Update Submitted that Met QC Criteria : | February 8, 2024 |
| Last Update Posted : | February 9, 2024 |